Physicochemical, microstructural, and histological evaluation of hexagonal boron nitride-reinforced mineral trioxide aggregate in experimental rat tibial bone defects Authors: Faruk Öztekin, Cevher Kürşat Macit, Turan Gürgenç, Zeynep Toprak, Serkan Dündar, Bünyamin Aksakal, İbrahim Hanifi Özercan Published: 2026 ABSTRACT AbstractBackgroundMineral trioxide aggregate (MTA) is a calcium silicate-based endodontic biomaterial with well-established sealing ability, biocompatibility, and hard-tissue induction potential; however, the extent to which its biological performance can be modulated by nanostructured reinforcements remains insufficiently defined. Hexagonal boron nitride (hBN) is a layered two-dimensional nanomaterial with high chemical stability, mechanical robustness, and growing relevance in regenerative biomaterials. Because no directly comparable in vivo study had evaluated hBN incorporation into an MTA matrix in a standardized rat tibial defect model, the present work was designed as an exploratory physicochemical and histological study.MethodsStandardized cylindrical defects (2.5 mm diameter, 4 mm depth) were created in the right tibial metaphysis of 40 systemically healthy rats randomly allocated to four groups (n = 10/group): empty defect control, pure MTA, MTA + 5 wt% hBN, and MTA + 10 wt% hBN. The study was conducted as a single 8-week in vivo experiment following institutional ethics approval. Pure MTA and hBN-modified composites were prepared under standardized mixing conditions and characterized qualitatively by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and energy-dispersive X-ray spectroscopy (EDX). After 8 weeks, tibiae were harvested, decalcified, paraffin-embedded, stained with hematoxylin-eosin, and scored semi-quantitatively for fibrous tissue, new bone formation, and osteoblastic cell presence. Non-parametric comparisons were performed using Kruskal-Wallis and Dunn-Bonferroni tests (α = 0.05).ResultsXRD and FT-IR analyses showed preservation of the principal calcium silicate phase architecture and hydration-related bonding environment of MTA after hBN incorporation, while SEM-EDX demonstrated a progressively denser and more hBN-rich surface organization in the modified groups, particularly at 10 wt% hBN. Histologically, both hBN-containing groups displayed significantly higher new bone formation and osteoblastic cell presence scores than the empty-defect control. Fibrous tissue scores were also higher in the hBN groups than in the control group, indicating that the tissue response should be interpreted as a modified fibro-osseous reparative profile rather than as simple suppression of fibrosis. Compared with pure MTA, the 10 wt% hBN formulation showed the most favorable overall trend within the tested range, although differences between 5 wt% and 10 wt% hBN were not statistically significant.ConclusionsWithin the boundaries of this exploratory 8-week rat tibial defect study, hBN could be incorporated into MTA without evidence of major physicochemical destabilization and with a more pronounced bone-related healing response than that observed in untreated control defects. The findings do not support an overextended claim of direct osteoblast activation or definitive concentration optimization; rather, they indicate that hBN-reinforced MTA is a promising proof-of-concept composite whose long-term remodeling behavior, mechanical performance, ion release, systemic safety, and true optimum hBN window require further quantitative investigation.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-026-08706-8.Keywords: Mineral trioxide aggregate, Hexagonal boron nitride, Rat tibial defect model, Exploratory biomaterials study, Calcium silicate cement, Physicochemical characterization, Bone healing Introduction The primary goals of endodontic treatment are to remove infected intraradicular tissue, reduce the microbial load within the root canal system, prevent recontamination, and establish a biological environment conducive to healing and regeneration of periradicular tissues. Microbial invasion and persistence within the root canal system are decisive in the initiation and progression of periapical lesions. Apical periodontitis is characterized by inflammation and destruction of periradicular tissues caused by etiological agents of endodontic origin [1, 2]. Although conventional chemomechanical preparation and obturation aim to eliminate infection and prevent its advancement, complete decontamination is often not achievable because of the complex anatomy of the root canal system, including inaccessible lateral canals, isthmuses, apical ramifications, and structured biofilm communities [3]. When non-surgical approaches are insufficient, periapical surgery becomes an important therapeutic option involving apical resection, curettage of pathological tissue, root-end cavity preparation, and retrograde sealing of the resected root-end cavity [3, 4]. A wide range of materials has historically been used for this purpose, including amalgam, gutta-percha, zinc oxide-eugenol cements, glass ionomer cements, Cavit, composite resins, gold foil pellets, and MTA [5]. However, the fact that these materials have been used clinically does not mean that any of them satisfies all desirable criteria under all operative conditions. In an ideal sense, a retrograde filling material should combine dimensional stability, sealing ability in the presence of moisture, radiopacity, handling suitability, antimicrobial or at least non-permissive behavior toward residual infection, cytocompatibility, and support for hard-tissue healing; continued development of improved calcium silicate systems is therefore still scientifically justified [4, 5]. MTA is a calcium silicate–based bioceramic widely used in endodontics as a root-end filling material, perforation repair agent, apexification material, and direct/indirect pulp capping material. Its formulation was originally derived from Portland cement and modified with bismuth oxide to achieve radiopacity suitable for clinical use. MTA consists of finely ground cement phases, primarily tricalcium silicate (C3S), dicalcium silicate (C2S), calcium aluminate phases, and calcium sulfate. When mixed with water, these phases undergo hydration reactions that yield calcium silicate hydrate (C–S–H) gels and calcium hydroxide. The C–S–H phase contributes to mechanical strength, while the released calcium hydroxide increases pH, providing antibacterial properties and supporting biocompatibility. The porous structure formed during setting enhances interaction with tissue fluids, promoting dentin-like mineral deposition and the formation of bioactive surface layers [4, 6, 7]. The high biocompatibility, excellent marginal sealing ability, moisture tolerance, and long-term dimensional stability of MTA result in superior clinical outcomes compared with traditional calcium hydroxide and glass ionomer–based materials [4–6]. Reducing iron oxide in white MTA formulations minimizes discoloration, while modern MTA derivatives have been further optimized by nanoscale particle refinement and incorporation of nanofillers, bioactive additives, and alternative radiopacifiers to improve hydration kinetics and mechanical strength. Research in this field has expanded considerably, focusing on the relationships among microstructure, composition, and functional behavior. Nanostructured phases such as hexagonal boron nitride (hBN), zirconia (ZrO2), silica (SiO2), and bioactive glass are increasingly being investigated for their interactions with MTA matrices and their effects on setting behavior, ion release, and biomechanical performance. Although hydroxyapatite [Ca10(PO4)6(OH)2] is the primary inorganic component of dental hard tissues, dentin also contains trace elements such as selenium (Se), fluorine (F), silver (Ag), and boron (B) [8]. Boron, in particular, plays important regulatory roles in dentin repair and mineralized tissue remodeling [8, 9]. In vitro studies have shown that boron modulates mineralized tissue-associated proteins and gene expression in osteoblasts, thereby enhancing osteoblast differentiation and matrix mineralization [9, 10]. Boron compounds have also been reported to increase trabecular and alveolar bone formation, reduce alveolar bone loss in osteoporotic models, and enhance bone–implant contact at intramedullary implant surfaces [11, 12]. These findings suggest that boron-containing phases may modulate bone healing not only systemically but also when locally incorporated into biomaterial carriers [9, 11–13]. Hexagonal boron nitride (hBN), a two-dimensional nanomaterial with a layered crystal structure analogous to graphite but white in appearance, is characterized by high chemical inertness, thermal stability, low friction coefficient, electrical insulation, and considerable mechanical strength [14, 15]. Nanostructured hBN phases have been shown to improve mechanical behavior when incorporated into medically relevant carrier systems such as hydroxyapatite, polymer matrices, and polymethyl methacrylate (PMMA), while also showing osteoblast-compatible cellular responses and, in some settings, antimicrobial or antibiofilm activity [16–19]. In the present manuscript, these PMMA- and hydroxyapatite-based examples are cited only as contextual precedent demonstrating that hBN has already been explored in biomaterial platforms; they are not experimental components of the current study. Accordingly, the rationale for investigating hBN in an MTA matrix is not that prior PMMA or hydroxyapatite combinations are directly transferable to endodontic cements, but rather that they provide a conceptual basis for considering hBN as a multifunctional reinforcing phase. The key unanswered question is whether a layered boron nitride additive can be introduced into a calcium silicate cement system without compromising phase stability while potentially modifying the biological tissue response after implantation. This distinction is critical because the hydration chemistry, setting behavior, and interfacial biology of MTA differ substantially from those of PMMA- or hydroxyapatite-dominant systems. In calcium silicate-based cement systems, hBN is attractive as a candidate nanofiller because its lamellar morphology and high specific surface area may influence interparticle organization, reduce crack propagation, and modify the microstructural compactness of the set cement. Importantly, however, these proposed advantages remain mechanistic expectations until they are verified experimentally within the MTA environment. For this reason, the present study was framed as an exploratory study rather than a definitive optimization study: its purpose was first to determine whether hBN could be incorporated into MTA while preserving the underlying physicochemical identity of the cement, and second to examine whether such incorporation was accompanied by a discernible in vivo histological signal. Despite the inherent osteoconductive and hard-tissue-forming potential of MTA, the in vivo consequences of adding hBN to this specific matrix have not been sufficiently clarified. Previous reports have described osteogenic or regenerative effects of boron-containing systems and hBN-containing scaffolds or composites [9, 15–20], yet those studies do not answer the more specific question of whether hBN-modified MTA behaves differently from unmodified MTA after implantation into bone. To the best of our knowledge, no prior animal study has directly evaluated histological healing in rat tibial defects filled with hBN-reinforced MTA. This gap provided the immediate scientific justification for the present investigation. Rat tibial bone defect models are widely used to evaluate osseous healing in a mechanically stable and reproducible setting. Such models permit standardized defect creation, controlled biomaterial placement, and semi-quantitative histological comparison of bone-related healing events across groups [21–23]. In the context of the present work, the tibial model was selected to provide an orthotopic bony environment in which fibrous tissue response, new bone formation, and osteoblastic cell presence could be compared systematically among pure MTA and hBN-modified formulations. Taken together, the established clinical relevance of MTA, the regulatory role of boron-containing phases in mineralized tissues, and the multifunctional physicochemical profile of hBN suggest that MTA-hBN composites may represent a biologically interesting class of modified retrograde biomaterials. Nevertheless, because the current evidence base remains preliminary, any claim of synergistic superiority must be tested experimentally rather than assumed a priori. The present study therefore sought to connect three levels of evidence within a single experimental design: (i) physicochemical preservation of the calcium silicate matrix, (ii) microstructural changes associated with increasing hBN content, and (iii) the corresponding histological response of bone defects after implantation. By integrating XRD, FT-IR, SEM-EDX, and in vivo histology, the work was intended to provide a technically broad but still exploratory data set capable of informing subsequent, more quantitative optimization studies. The aim of this study was to evaluate pure MTA, MTA + 5 wt% hBN, and MTA + 10 wt% hBN in standardized rat tibial bone defects with respect to fibrous tissue response, new bone formation, and osteoblastic cell presence. Our working hypothesis was intentionally exploratory: incorporation of hBN at experimentally feasible concentrations would preserve the physicochemical identity of MTA and could modify the tissue response in a direction compatible with improved bone healing. The study was not designed to define a definitive optimum hBN concentration, but rather to generate the first integrated in vivo data set on this specific MTA-hBN combination. Materials and methods Preparation of pure MTA and hBN-reinforced MTA composites Pure MTA and composites containing 5 wt% and 10 wt% hBN were prepared using a standardized powder-liquid protocol in which the hBN fraction was the only intended compositional variable. Commercial white mineral trioxide aggregate (Angelus White MTA, Angelus, Londrina, PR, Brazil) was used as the base cement, and hBN nanoparticles with an approximate primary particle size of 40 nm were obtained from Nanografi (Ankara, Turkiye). The two hBN levels were selected as experimentally workable incorporation ranges intended to probe whether a low-to-moderate reinforcement window could be achieved without gross loss of handling or set-matrix integrity. The study was initiated in January 2022 following the approval of the relevant ethics committee, and all material preparation and subsequent experimental procedures were carried out within the approved study framework. A homogeneous distribution of hBN within the MTA powder phase was prioritized before hydration. Accordingly, hBN nanoparticles were first dispersed in a small volume of distilled water in a benchtop fixed-frequency ultrasonic bath for approximately 10–15 min under ambient laboratory conditions in order to reduce agglomeration. The resulting suspension was then dried at 60–70 °C and lightly ground to recover a fine hBN powder prior to blending. Although this ultrasonic dispersion step was kept consistent throughout the study, the nominal bath operating frequency was not itself treated as an analytical variable in the present experimental design. The recovered hBN powder was mixed with the dry MTA powder in an agate mortar for approximately 15 min to obtain visually homogeneous powder blends. For hydration, a constant powder-to-water ratio of 3:1 (by weight) was used for all formulations so that the observed differences could be interpreted primarily in relation to hBN content rather than liquid proportion. Mixing was performed on a sterile glass slab by gradual incorporation of powder into liquid and spatulation for approximately 60 s until a cohesive, clinically insertable paste was obtained. The same basic handling sequence was used for pure MTA, MTA-5hBN, and MTA-10hBN. The prepared pastes were placed with slight overfilling into stainless-steel or PTFE molds, and the surfaces were standardized using Mylar strips and glass slides to obtain flat upper surfaces. Specimens were cured at 37 °C and approximately 95% relative humidity for 24 h to allow early hydration and set development. After curing, specimens were maintained at 37 °C in distilled water or phosphate-buffered saline, depending on the downstream characterization step. Serial pH monitoring, scheduled solution refreshment, and continuous independent logging of environmental stability were not predefined analytical variables in this exploratory protocol and should therefore be interpreted as methodological boundaries rather than as unreported controlled outcomes. The three formulations used in this study were designated as pure MTA, 5 wt% hBN-reinforced MTA (MTA-5hBN), and 10 wt% hBN-reinforced MTA (MTA-10hBN). Preparation of all three formulations was technically successful and yielded cohesive set materials suitable for both laboratory characterization and in vivo implantation. The formulations were prepared repeatedly under the same standardized protocol until sufficient material had been obtained for the characterization specimens and the surgical procedures. Because the physicochemical characterization in the present work was qualitative and representative rather than replicate-based inferential materials testing, the preparation stage is reported as standardized successful fabrication rather than as a formal replicate experiment. From a formulation standpoint, the 5 wt% and 10 wt% hBN levels should be understood as deliberate exploratory windows rather than as exhaustively optimized compositions. In calcium silicate cements, even modest changes in powder composition can influence wetting, particle packing, hydration progression, and paste cohesiveness during handling. The present study therefore prioritized technically feasible incorporation levels that could still be mixed and inserted in a clinically relevant manner. This is important because a reinforcing phase that performs well in a purely analytical specimen may still be unsuitable if it causes impractical handling or visible phase segregation during defect filling. Within this context, successful preparation of both hBN-containing groups constitutes a relevant result in itself: it demonstrates that hBN can be introduced into the MTA powder phase at experimentally meaningful levels without obvious macroscopic incompatibility during paste formation, curing, or implantation. The stepwise preparation workflow used to produce pure MTA, MTA-5hBN, and MTA-10hBN is summarized in Fig. 1. Schematic production flow diagram illustrating dispersion of hBN, dry blending with mineral trioxide aggregate, standardized powder-liquid mixing, molding/curing, and preparation of pure MTA, MTA-5hBN, and MTA-10hBN composites for subsequent characterization and implantation Structural, morphological, and chemical characterization techniques The structural, morphological, and chemical characteristics of pure MTA and hBN-reinforced MTA were evaluated using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and energy-dispersive X-ray spectroscopy (EDX). XRD measurements were obtained with an Empyrean diffractometer (PANalytical, Almelo, The Netherlands) using Cu Kalpha radiation (lambda = 1.5406 A) at 40 kV and 40 mA over a 2theta range of 10°-90°. In the present study, XRD was interpreted qualitatively to determine whether hBN altered phase identity, phase visibility, and overall crystallographic stability of the MTA matrix; crystallite-size, lattice-strain, and preferred-orientation calculations were not performed. FT-IR spectra were recorded over the 4000 –400 cm− 1 range using a Nicolet iS5 spectrometer (Thermo Scientific, Waltham, MA, USA). Particular attention was paid to the O-H/H-O-H bands associated with hydration products, carbonate-related bands, the silicate vibration region characteristic of the calcium silicate framework, and the B-N spectral region expected after hBN incorporation. As with XRD, FT-IR was used to assess preservation of the principal chemical environment and emergence of additive-related vibrations at a qualitative level rather than to derive kinetic or fully quantitative compositional parameters. Surface morphology and microstructural organization were examined by SEM (Sigma 300, ZEISS, Oberkochen, Germany). SEM observations focused on particle packing, interparticle voids, hydration-related surface heterogeneity, and the presence of lamellar or fine particulate features plausibly associated with hBN dispersion. Particular attention was directed to whether increasing hBN loading altered surface compactness, intergranular continuity, or the distribution of hydrated and unhydrated regions within the set cement. EDX point analysis and elemental mapping were performed in conjunction with SEM to verify the presence and spatial distribution of Ca, Si, O, and Bi characteristic of MTA together with B and N attributable to hBN. Thus, EDX was included as an explicit methodological component of the present study rather than only as a supporting spectrum. Its purpose was to evaluate whether the reinforcing phase could be detected on the composite surface and whether its distribution appeared broadly homogeneous at the representative qualitative level. The combined use of XRD, FT-IR, SEM, and EDX enabled a multi-level but deliberately non-overstated characterization strategy that linked phase preservation, functional-group stability, microstructural organization, and additive-related elemental distribution in the hBN-reinforced MTA composites. This multi-modal analytical strategy was intentionally designed to reduce overreliance on any single technique. XRD alone can indicate whether the major crystalline phases remain detectable, but it cannot fully describe bonding environments or surface organization. FT-IR complements this by clarifying whether hydration-related and silicate-associated vibrations remain stable after additive incorporation. SEM then provides the spatial and morphological context needed to interpret whether the additive coincides with visible changes in particle packing and interfacial organization, whereas EDX confirms whether boron- and nitrogen-containing regions are actually present at the analyzed surfaces. By integrating these complementary layers of evidence, the present study sought to construct a technically coherent interpretation of the composite rather than a fragmented set of isolated observations. Animal model and experimental design This study was approved by the Animal Experiments Ethics Committee of Firat University (Decision No: 2022/02). All procedures were performed in accordance with institutional guidelines for the care and use of laboratory animals and are reported in line with the ARRIVE 2.0 reporting framework [24, 25]. The in vivo component was conducted as a single postoperative 8-week experiment. Because directly comparable in vivo effect-size data for hBN-modified MTA were not available at the design stage, the study was planned as an exploratory animal experiment rather than as a confirmatory trial powered on a known formulation-specific difference. A practical minimum of eight rats per group was considered necessary for ordinal histological comparison; this number was increased to ten per group to offset potential perioperative loss and biological variability, yielding a total of 40 rats. After acclimatization, animals were randomly allocated to four groups, and one standardized defect was created in the right tibia of each animal. The unilateral design was selected to maintain a uniform operative field and avoid bilateral surgery, but it also prevented paired within-animal comparison and is therefore acknowledged as a design limitation. Control group (n = 10): in Group 1, a standardized tibial defect was created but no defect-filling biomaterial was placed. MTA group (n = 10): in Group 2, defects created in the corticocancellous region of the right tibial metaphysis (2.5 mm diameter, 4 mm depth) were filled with pure MTA. Animals were sacrificed at the end of postoperative week 8. MTA + 5% hBN group (n = 10): in Group 3, defects created in the corticocancellous region of the right tibial metaphysis were filled with MTA containing 5 wt% hBN. Animals were sacrificed after 8 weeks. MTA + 10% hBN group (n = 10): in Group 4, defects created in the corticocancellous region of the right tibial metaphysis were filled with MTA containing 10 wt% hBN. Animals were sacrificed at the end of postoperative week 8. Surgical procedure and defect creation Surgical procedures were conducted under general anesthesia in aseptic conditions. Anesthesia was induced intraperitoneally with ketamine (87 mg/kg; Francotar®, Virbac do Brasil Indústria e Comércio, Roseira, Brazil) in combination with xylazine (13 mg/kg; Rompum®, Bayer S.A., Leverkusen, Germany). Following skin preparation, a full-thickness incision was made over the tibial crest, and the soft tissues were carefully dissected to expose the metaphyseal region of the tibia. Standardized cylindrical bone defects measuring 4 mm in height and 2.5 mm in diameter were created using a trephine bur (3i Implant Innovations Inc., Palm Beach Gardens, FL, USA) under continuous saline irrigation to minimize thermal injury. The experimental biomaterials were then gently inserted into the defects with controlled pressure by an experienced operator to improve procedural standardization. Upon completion of the surgical intervention, the incisions were closed with 3 − 0 Ethilon nylon sutures (Ethicon, Edinburgh, Scotland). Postoperative observation, supportive medication, and euthanasia Postoperatively, all animals received penicillin (50 mg/kg; Amoxlav, Provet, Turkey) for infection prophylaxis and tramadol hydrochloride (0.1 mg/kg; Tramadolor, Turkey) for analgesic support as part of the routine immediate perioperative regimen under veterinary supervision. The exact day-by-day duration of this supportive medication schedule was not predefined as an analytical variable of the study. Animals were observed during the healing period for general postoperative recovery, and each animal remained in follow-up for 8 weeks after surgery. At the endpoint, animals were euthanized under deep anesthesia and the tibiae were harvested for histological evaluation. Histological processing and scoring method The harvested tibiae were fixed in 10% formaldehyde for 72 h and subsequently demineralized in 10% formic acid. After demineralization, samples were processed routinely, embedded in paraffin, sectioned at 6 μm thickness, and stained with hematoxylin-eosin for light-microscopic evaluation. Histology was performed only at the 8-week endpoint; therefore, the protocol was designed to characterize the tissue status at a single reparative time point rather than to resolve early-versus-late temporal dynamics. Osteoblastic cell presence was scored as follows: absence = 0, mild presence = 1, moderate presence = 2, and intense presence = 3. New bone formation was scored as: no new bone = 0, low new bone = 1, moderate new bone = 2, and extensive new bone = 3. Fibrous tissue response was scored as: no visible fibrosis = 0, superficial or focal fibrous tissue = 1, superficial diffuse or deep localized fibrous tissue = 2, and deep and widespread fibrous tissue = 3 [26]. This scoring system was intentionally semi-quantitative and was used to permit ordinal between-group comparison at the single predetermined endpoint. Although more advanced quantitative methods such as histomorphometric area fraction analysis or micro-computed tomography would undoubtedly strengthen the biological evaluation, semi-quantitative histological scoring remains informative in early-stage biomaterials studies when the objective is to detect whether a material modifies the overall tissue pattern at a defined endpoint. In the present study, the scoring system allowed the three principal biological features of interest - fibrous tissue, new bone, and osteoblast-associated lining cells - to be compared on a common ordinal scale across all groups. The limitation is not that such scoring lacks value, but that its interpretive range is narrower than that of fully quantitative three-dimensional methods. This distinction is made explicit here to prevent overinterpretation of the histological dataset. Statistical analysis Statistical analyses were performed using IBM SPSS Statistics version 22 (Endicott, New York, USA). The Shapiro-Wilk test was used to assess distributional assumptions. Because the histological outcomes were ordinal and did not satisfy normality assumptions, results were summarized as median (minimum-maximum). Overall group comparisons were performed with the Kruskal-Wallis H test and followed, where appropriate, by Dunn-Bonferroni post-hoc analysis for pairwise comparisons. The level of statistical significance was set at α = 0.05. Results Composite preparation and general observations All three formulations could be prepared successfully under the standardized protocol described above. Pure MTA, MTA-5hBN, and MTA-10hBN each produced cohesive pastes that could be placed into molds and handled surgically without visible macroscopic phase separation. With increasing hBN content, the material surface displayed progressively more additive-associated particulate/lamellar features in subsequent microscopy, but hBN incorporation did not prevent setting or the generation of representative specimens for physicochemical characterization and implantation. Because the characterization strategy of the present study was qualitative and representative, the findings reported below should be interpreted as convergent evidence of phase preservation, additive detection, and microstructural reorganization rather than as a full quantitative optimization matrix. Nevertheless, the combined dataset was sufficient to compare how increasing hBN content influenced the observable behavior of the MTA matrix. XRD analysis The diffraction behavior observed in pure MTA, MTA-5hBN, and MTA-10hBN demonstrates how the principal crystallographic identity of the calcium silicate matrix was preserved across increasing additive concentrations (Fig. 2). The XRD profile of pure MTA showed the expected sharp reflections of a crystalline calcium silicate-based cement and provided the reference pattern against which the modified materials were interpreted. Across all groups, the dominant MTA-related peaks remained detectable within comparable angular regions, indicating preservation of the underlying phase architecture. Qualitative XRD patterns of pure MTA, MTA-5hBN, and MTA-10hBN composites showing preservation of the principal calcium silicate phase pattern with increasing visibility of additive-related reflections after hBN incorporation At the 5 wt% hBN level, no obvious peak displacement suggesting major phase transformation was observed. Instead, the diffractogram displayed the superimposition of additive-related reflections while maintaining the recognizable MTA-associated peak pattern. In other words, hBN appeared to enter the composite as a detectable reinforcing phase rather than as a reactant that reorganized the primary crystallographic framework of the cement. Because the present XRD analysis was qualitative, the data were interpreted in terms of phase preservation and reflection visibility rather than by Rietveld refinement, Scherrer crystallite-size calculation, or lattice-strain estimation. When hBN content was increased to 10 wt%, additive-related reflections became more prominent, consistent with the higher concentration of the boron nitride phase. Importantly, however, the main MTA-related reflections remained present without evidence of gross peak loss or the appearance of a new dominant reaction-derived phase. This indicates that even at the higher incorporation level tested here, hBN did not produce an overt crystallographic collapse or replacement of the calcium silicate matrix; rather, it altered the overall pattern by increasing the visibility of the additive contribution. Taken together, the XRD findings support the interpretation that hBN can be incorporated into MTA as a physically coexisting phase while preserving the principal crystallographic identity of the cement matrix. At the same time, the present data should not be overread: quantitative information on crystallite size, preferred orientation, domain strain, and hydration kinetics was beyond the analytical scope of this study and remains an important target for future work. For calcium silicate biomaterials, preservation of phase identity is not a purely academic consideration; it is closely related to hydration behavior, ion release, pH development, setting stability, and ultimately the biological microenvironment established around the implanted cement. If the addition of hBN had induced gross phase loss or transformation, any subsequent biological differences could have reflected destabilization of the base cement rather than a meaningful reinforcing effect. The fact that the principal MTA-related diffraction profile remained recognizable in both hBN-containing groups therefore provides an essential interpretive anchor for the rest of the study. It supports the notion that the subsequent microstructural and histological findings arose in the setting of retained cement identity rather than physicochemical collapse of the parent biomaterial. FT-IR analysis: functional group distribution and chemical stability The FT-IR spectra of pure MTA, MTA-5hBN, and MTA-10hBN were evaluated to determine whether hBN altered the dominant functional-group environment of hydrated MTA (Fig. 3). The overall preservation of the spectral profile across the 4000 –400 cm-1 region indicates that the main bonding architecture of the calcium silicate matrix remained stable despite additive incorporation. Representative FT-IR spectra of pure MTA, MTA-5hBN, and MTA-10hBN composites, illustrating preservation of the dominant hydration-related and silicate-associated bands together with increasing B-N-related spectral contributions after hBN incorporation Pure MTA exhibited the expected set of broad and discrete bands associated with hydrated calcium silicate-based cements, including O-H stretching features related to hydroxyl groups and adsorbed water, H-O-H bending signals, carbonate-associated bands, and the silicate vibration region characteristic of the MTA framework [27–32]. These features are consistent with the presence of hydration products and the maintained integrity of the calcium silicate system after setting. In the MTA-5hBN group, the dominant MTA-related bands remained in comparable spectral positions, indicating that the addition of hBN did not provoke obvious chemical rearrangement of the main hydration-related bond network. Additional or more intense signals in the B-N-related spectral region were consistent with the presence of the reinforcing phase. The absence of marked shifts in the major silicate bands suggests that hBN behaved primarily as a physically incorporated additive rather than as a phase that redefined the bonding environment of the cement. In the MTA-10hBN group, additive-related B-N features became more pronounced, which was expected at the higher loading level. Even so, the characteristic O-H, carbonate, and silicate-related bands of the cement matrix remained visible without a clear pattern of band displacement that would indicate gross chemical destabilization. Thus, higher hBN content changed spectral prominence but did not provide evidence of a fundamentally different hydrated cement chemistry within the qualitative analytical scope of the study. Overall, the FT-IR data corroborate the XRD results by supporting chemical compatibility between hBN and the hydrated MTA matrix. The spectra indicate preservation of the principal functional-group environment together with increasing detectability of B-N-related vibrations as the hBN content rises. As with XRD, however, the present interpretation is qualitative and does not substitute for deeper kinetic or quantitative spectroscopic modeling. This preservation of the major FT-IR profile is especially relevant because hydrated calcium silicate cements derive much of their biological behavior from the stability of hydration products and the persistence of the silicate network. A finding of strong band displacement or disappearance would have raised concern that hBN was fundamentally modifying the chemical setting environment of the cement. Instead, the present spectra suggest coexistence of the additive with the hydrated matrix. In practical terms, this means that the hBN phase appears to contribute its own vibrational signature without replacing the dominant spectroscopic identity of MTA. Such behavior is compatible with the broader concept of hBN as a structurally distinct but chemically non-disruptive reinforcing phase in a calcium silicate host. SEM-EDX analysis: microstructural organization and elemental distribution SEM analysis of pure MTA revealed the expected heterogeneous calcium silicate-based surface morphology composed of irregular angular particles, locally separated interparticle spaces, and hydration-related surface heterogeneity (Fig. 4). This microstructural pattern is consistent with the coexistence of hydrated phases, residual unhydrated particles, and a relatively non-uniform surface topography. Corresponding EDX spectra were dominated by Ca, Si, O, and radiopacifier-related elements, confirming the characteristic compositional profile of the base cement. Representative SEM-EDX characterization of the three formulations. For each material set, the first image shows a lower-magnification SEM view, the second image a higher-magnification SEM view, the colored panel an elemental distribution map of the analyzed region, and the final panel the corresponding EDX spectrum. a Pure MTA; b MTA-5hBN; c MTA-10hBN After incorporation of 5 wt% hBN, SEM images showed a more compact interparticle arrangement with finer particulate/lamellar features distributed between or across the MTA grains. These features are compatible with partial dispersion of the layered hBN phase within the cement surface. EDX analysis of the same formulation demonstrated detectable B and N signals, supporting successful incorporation of the additive and suggesting that the hBN phase was not lost during processing or setting. The 10 wt% hBN group displayed the most pronounced microstructural modification. SEM revealed more extensive coverage of the surface by fine lamellar/particulate structures and a further reduction in conspicuous intergranular void space, producing a denser apparent surface organization. In parallel, EDX spectra and maps showed stronger B and N contributions, which is consistent with the higher hBN loading and with broader additive representation at the analyzed surface sites. These findings indicate a concentration-related increase in the visible contribution of hBN to the composite surface. Collectively, the SEM-EDX results indicate that hBN modifies the surface organization of MTA in a concentration-related manner without providing evidence of destructive chemical transformation of the underlying cement matrix. The data support successful incorporation of the reinforcing phase, a shift toward a denser microstructural appearance, and progressive detectability of boron- and nitrogen-containing regions as hBN loading increases. The concentration-related change in visible surface organization may also help explain why the biological response did not simply mirror that of pure MTA. Cells interact first with the material interface rather than with an abstract bulk composition, and surface continuity, local roughness, particle exposure, and additive distribution can influence protein adsorption, fluid interaction, and the organization of reparative tissue at the defect site. While the present study was not designed to measure these interfacial mechanisms directly, the SEM-EDX findings provide a morphologically plausible basis for why the hBN-containing groups might display a different tissue pattern at 8 weeks. In this sense, the microscopy results serve as a bridge between retained phase identity and altered biological behavior. Histological evaluation: fibrous tissue, new bone formation, and osteoblastic cell presence Histological sections obtained from the rat tibial defects were examined to compare fibrous tissue response, new bone formation, and osteoblastic cell presence among the experimental groups. Because the scoring system was ordinal, results are presented as semi-quantitative median (minimum-maximum) scores, and Table 1 should be interpreted as a comparative overview of the 8-week tissue status rather than as a volumetric morphometric analysis. Table 1Semi-quantitative comparison of 8-week histological scores for fibrous tissue response, new bone formation, and osteoblastic cell presence among the Control, MTA, MTA-5hBN, and MTA-10hBN groupsMeasurementControl (1)MTA (2)MTA-5hBN (3)MTA-10hBN (4)p-valuePairwise p*Fibrous tissue1 (1–1)1 (1–2)2 (1–3)2 (2–3)0,0021–2:1,0001–3:0,0031–4:0,0012–3:0,0562–4:0,0273–4:1,000New bone1 (1–1)1 (1–2)2 (2–3)2 (1–3)0,0021–2:1,0001–3:0,0021–4:0,0012–3:0,0602–4:0,0403–4:1,000Osteoblastic cell presence1 (1–1)1 (1–2)2 (2–3)2 (1–3)0,0021–2:1,0001–3:0,0021–4:0,0012–3:0,0602–4:0,0403–4:1,000Data are presented as median (minimum-maximum) semi-quantitative scores. Fibrous tissue: 0 = none, 1 = focal/superficial, 2 = superficial diffuse or deep localized, 3 = deep and widespread. New bone: 0 = none, 1 = low, 2 = moderate, 3 = extensive. Osteoblastic cell presence: 0 = absent, 1 = mild, 2 = moderate, 3 = intense. p: Kruskal-Wallis test; p*: Dunn-Bonferroni post-hoc test Semi-quantitative comparison of 8-week histological scores for fibrous tissue response, new bone formation, and osteoblastic cell presence among the Control, MTA, MTA-5hBN, and MTA-10hBN groups 1–2:1,000 1–3:0,003 1–4:0,001 2–3:0,056 2–4:0,027 3–4:1,000 1–2:1,000 1–3:0,002 1–4:0,001 2–3:0,060 2–4:0,040 3–4:1,000 1–2:1,000 1–3:0,002 1–4:0,001 2–3:0,060 2–4:0,040 3–4:1,000 Data are presented as median (minimum-maximum) semi-quantitative scores. Fibrous tissue: 0 = none, 1 = focal/superficial, 2 = superficial diffuse or deep localized, 3 = deep and widespread. New bone: 0 = none, 1 = low, 2 = moderate, 3 = extensive. Osteoblastic cell presence: 0 = absent, 1 = mild, 2 = moderate, 3 = intense. p: Kruskal-Wallis test; p*: Dunn-Bonferroni post-hoc test Statistical comparison showed no significant difference between the control and pure MTA groups with respect to fibrous tissue score, new bone score, or osteoblastic cell presence score (p > 0.05). In contrast, both hBN-containing groups showed significantly higher scores than the control group for all three parameters (fibrous tissue, new bone, and osteoblastic cell presence; p < 0.05). When the pure MTA group was compared with MTA-5hBN, the pairwise differences did not reach statistical significance after Dunn-Bonferroni correction, although the medians trended upward in the hBN-containing material. Comparison of pure MTA with MTA-10hBN showed significantly higher fibrous tissue and new bone scores in the 10 wt% hBN group, whereas the difference in osteoblastic cell presence did not reach statistical significance. No statistically significant difference was found between MTA-5hBN and MTA-10hBN. Accordingly, the histological dataset indicates a more pronounced fibro-osseous reparative profile in the hBN-modified groups, particularly at 10 wt% hBN within the tested range, but it does not support the simplified interpretation that hBN uniformly reduced fibrous tissue. Microscopic examination was consistent with the numerical scores. The control defects showed limited reparative tissue organization and comparatively sparse bone-related healing. Pure MTA showed a modest improvement in tissue organization but remained close to the control group in semi-quantitative scoring. In the MTA-5hBN and MTA-10hBN groups, more extensive reparative tissue occupied the defect area, with greater evidence of newly formed bone and more conspicuous osteoblast-lined surfaces; however, this was accompanied by higher fibrous/fibrovascular tissue scores rather than by complete elimination of fibrous tissue. Thus, the histological response to hBN should be interpreted as a modified healing pattern with increased bone-related features and concurrent fibrocellular repair, not as a purely fibrosis-suppressive effect. Representative hematoxylin-eosin-stained sections for all groups are shown in Fig. 5. Representative hematoxylin-eosin-stained sections from rat tibial defects in the Control, MTA, MTA-5hBN, and MTA-10hBN groups, illustrating differences in defect fill, fibrous/fibrovascular tissue, newly formed bone, and osteoblast-rich lining cells at the 8-week endpoint. Scale bar = 100 μm This mixed fibro-osseous pattern deserves particular attention because it underscores the importance of endpoint timing in bone-healing studies. A snapshot taken at 8 weeks can show active reparative tissue, osteoblast-lined surfaces, and persistent fibrous/fibrovascular components at the same time, especially in defects that are not yet fully remodeled. Consequently, the coexistence of more new bone and more fibrous tissue in the hBN groups should not be treated as internally contradictory. Rather, it suggests that the material may be altering the organization or tempo of the healing response. Whether this represents a transient intermediate stage on the path toward more complete osseous maturation or a more persistent interface cannot be decided from the present single-time-point design and remains a key question for follow-up studies. Discussion In this exploratory study, hBN addition to MTA was evaluated not only through histological tissue response but also through crystal-structural, molecular-bonding, and microstructural analyses using XRD, FT-IR, SEM, and EDX. Considered together, the data indicate that incorporation of hBN did not disrupt the principal calcium silicate architecture of the cement; rather, it altered the observable surface organization and was associated with a modified 8-week tissue response. The originality of the work lies in linking these different analytical levels within the same in vivo experiment. At the same time, the study should be interpreted as an early proof-of-concept dataset rather than as a definitive optimization study. A further strength of the present work is that it does not attempt to derive a biological conclusion from histology in isolation. In biomaterials research, there is a recurrent risk of attributing a favorable tissue outcome to a modifier without verifying whether the modifier destabilized the parent material or altered its interface in an unintended way. By contrast, the present study first established that the principal crystallographic and spectroscopic identity of MTA was retained, then demonstrated that hBN was detectable at the microstructural and elemental levels, and only then interpreted the histological findings. This sequence is methodologically important because it allows the biological observations to be contextualized within the actual state of the material rather than within an assumed formulation concept. XRD analyses performed at the structural level demonstrated that the characteristic diffraction peaks of Ca-silicate phases specific to MTA were preserved in all groups, including pure MTA, 5% hBN-modified MTA, and 10% hBN-modified MTA. The addition of hBN did not cause any meaningful shift in peak positions, indicating that the fundamental crystal lattice remained unchanged after modification and that hBN did not react with the MTA matrix to form new crystalline phases. This finding is consistent with previous reports supporting the existence of stable phase structures in MTA derivatives, particularly with respect to the main phases composing MTA, such as Ca3SiO5 (tricalcium silicate) and Ca2SiO4 (dicalcium silicate). For example, one study reported that XRD analysis of Ca-silicate–based materials such as MTA-Plus, MTA Angelus, and DiaRoot BioAggregate revealed common detection of tricalcium silicate, dicalcium silicate, and aluminum-containing phases, with minimal variation in phase positions among materials [33]. These findings suggest that hBN does not compromise the crystalline phase stability of the MTA matrix. In particular, the absence of peak shifts and the maintenance of sharp, well-defined peaks indicate that hBN does not adversely affect one of MTA’s key engineering advantages phase stability. Furthermore, the lack of any amorphous halo in the XRD patterns supports the preservation of long-range crystalline order and shows that hBN incorporation does not increase the amorphous content or induce crystal degradation. This outcome can be associated with the dimensional stability and phase robustness that make MTA desirable in clinical settings and demonstrates that hBN does not exert a negative influence in this regard. However, the literature does report subtle changes in phase parameters in some Ca-silicate–based materials. For instance, in a study entitled “X-ray diffraction analysis of various calcium silicate-based materials,” slight peak shifts and the formation of new phases were documented in different Ca-silicate–based cements [34]. In this context, the fact that peak positions remained stable in the present study despite hBN incorporation at 5% and 10% suggests that hBN does not cause in-phase dissolution or phase transformation within the MTA matrix and instead behaves predominantly as a physical reinforcement. Considering the intrinsic crystal structure of hBN (e.g., in studies examining hBN nanosheets in biomaterials) [35], its compatibility with the MTA matrix and its ability to reinforce without disrupting the underlying crystal architecture can be regarded as a desirable property in composite material design. This supports the view that the additive phase acts in an “inert” or “passive” manner within the matrix, maintaining the fundamental phase structure. Nonetheless, the structural interpretation has clear analytical boundaries. The present XRD dataset allowed comparison of peak presence, peak position stability, and the increasing visibility of additive-related reflections, but it was not processed through Rietveld refinement, Scherrer analysis, Williamson-Hall modeling, or texture/orientation analysis. Consequently, the current manuscript cannot claim quantitative information on crystallite size, lattice strain, microstrain evolution, or preferred orientation of hBN within the matrix. Recognizing this limitation strengthens rather than weakens the present findings, because it aligns the claims of the paper with the actual evidential scope of the measurements. Finally, it is important to consider how these structural findings relate to biological performance. Preservation of the crystal phase structure in the presence of hBN is advantageous for cell–matrix interactions, ion release behavior, and the material’s balanced function in a biological environment. When assessed in conjunction with surface morphology and additive phase distribution obtained from SEM/EDX analyses, the triad of structural stability, microstructural improvement, and biological compatibility becomes more meaningful. In summary, the XRD data are consistent with the literature in showing that hBN does not cause crystal phase degradation within the MTA matrix, and that phase identity and long-range order are preserved properties that are highly desirable in composite design. However, more detailed parameters such as crystal domain size, microstrain, and preferred orientation of the additive phase could also be evaluated, and future studies incorporating these analyses would provide a more comprehensive understanding. FT-IR analyses complement the crystal-structural findings from XRD at the molecular bonding level. The persistence of broad O–H stretching bands around 3200–3600 cm− 1 and H–O–H bending bands around 1600–1650 cm− 1 in all groups indicates that MTA shares a similar chemical environment in terms of hydration products. This is consistent with reports that Ca(OH)2 formation and adsorbed water produce characteristic broad bands in the FT-IR spectra of hydrated Ca-silicate cements [27]. The presence of bands in the 1400–1500 cm− 1 region corresponding to carbonates further confirms the formation of CaCO₃ by reaction of Ca ions with ambient CO2, a frequently observed carbonation product in MTA and other Ca-silicate cements. These observations align with studies indicating that carbonation is a surface-dominant phenomenon that increases over time [28]. Strong bands observed between 900 and 1100 cm− 1 in the spectra of all groups are located at similar wavenumbers and are associated with Si–O, Si–O–Si, and Si–O–Ca vibrations. This region represents the principal FT-IR signature of the calcium silicate hydrate (C–S–H) gel. The lack of band shifts in this region in modified groups indicates that the Si-based skeletal framework of MTA remains unaffected by hBN addition. Similarly, studies showing that C–S–H gel stability is preserved despite different modifications highlight the chemical robustness of Ca-silicate phases [29]. Thus, the absence of changes in chemical bond structure after hBN addition is consistent with the inherently modification-resistant nature of the MTA cement matrix. In hBN-containing groups, particularly increased band intensities around 1300–1400 cm− 1 corresponding to B–N stretching vibrations indicate incorporation of the additive phase into the FT-IR spectrum. This spectral region has been identified in the literature as characteristic for the “E1u B–N stretching” modes of hexagonal boron nitride [30]. Additionally, bands in the 700–800 cm⁻¹ region are associated with the “out-of-plane B–N–B bending” modes of hBN, and the progressive increase in these band intensities with higher hBN concentrations closely matches previously reported behavior [31]. The more pronounced appearance of these vibrations particularly in the 10% hBN group reflects the direct contribution of the increased hBN content to the spectrum and indicates that hBN retains its chemical integrity as a separate phase within the composite. When all of these findings are considered together, the FT-IR data strongly support the XRD results: the Ca-silicate framework of MTA is not affected by hBN addition, and no new chemical bond types or reaction products are formed. The fact that hBN contributes to the spectrum solely through its own characteristic vibrations supports the chemical stability and phase compatibility of the composite structure. This aligns with studies reporting that the addition of various modifiers to Ca-silicate cements typically does not alter the primary bonding environment, although additional phase-specific vibrations may appear in the spectrum [32]. It has also been emphasized that in composite systems reinforced with nanostructured phases, physical rather than chemically reactive integration of the additive is often desirable and can be advantageous from a biocompatibility perspective [36]. Accordingly, the FT-IR results demonstrate that the incorporation of hBN preserves the chemical integrity of MTA, does not disrupt the Ca-silicate framework, and behaves as a non-reactive, stable phase within the composite. The absence of band shifts despite increasing hBN ratios indicates molecular-level stability and supports the notion that the composite is likely to exhibit predictable behavior in biological environments. SEM analyses provide important evidence at the microstructural level that corroborate the structural stability demonstrated by XRD and FT-IR. The irregular, angular Ca-silicate particles with distinct interparticle voids observed in pure MTA micrographs are consistent with the characteristic porous morphology of MTA after hydration reported in the literature. This morphology reflects the coexistence of Ca(OH)2 crystals, C–S–H gel, and unhydrated silicate phases at the surface [37]. Such heterogeneity in pure MTA is an important determinant of both mechanical strength and biological adhesion. Moreover, the porous structure observed by SEM is associated with volumetric changes occurring during the hydration process and the formation of a porous matrix that facilitates ionic diffusion [38]. With the addition of hBN particularly in the 5% hBN group interparticle voids between MTA grains were partially reduced, the interfaces appeared more compact, and the surface exhibited layered, fine particulate structures. This layered microstructure is consistent with the well-known two-dimensional lamellar morphology of hBN. In the literature, the addition of hBN to polymeric and ceramic matrices has been reported to increase surface compactness and strengthen interparticle bonding [39]. A similar mechanism may be operative within the MTA matrix: nanosheet-like hBN structures may establish physical contact with Ca-silicate particles, stabilizing the interface and enhancing interparticle connectivity. This likely explains the more compact morphology observed in the 5% hBN group. EDX analyses provide the compositional basis for these microstructural changes. The predominance of Ca, Si, and O in the pure MTA group is an expected finding and correlates with Ca3SiO5, Ca2SiO4, and C–S–H-related phases identified by XRD. The dominance of Ca and Si in EDX profiles of MTA has been strongly associated in the literature with the fundamental Ca-silicate structure responsible for the material’s biocompatibility [37]. In this context, the elemental distribution observed in the pure MTA group is fully consistent with previous data. The structural and chemical effects of hBN incorporation are clearly reflected in the EDX results. The 5% hBN group exhibited recognizable B and N signals distributed relatively homogeneously across the surface. This suggests that hBN is dispersed physically within the matrix and integrated as a separate phase without undergoing chemical reaction. Similar observations have been reported in studies where nano-sized reinforcements were added to Ca-silicate cements, showing homogeneous distribution of the additive phase across the surface without complete coverage of the matrix [38]. This behavior is attributed to the surface energy, layered structure, and dispersion capacity of nanostructured additives. The present findings indicate that hBN provides an effective surface modification within the MTA matrix in a similar manner. Microstructural changes observed in the 10% hBN group indicate that increasing the amount of additive produces a more pronounced “coating effect” of hBN on the MTA surface. SEM images demonstrated that MTA particles were extensively covered with hBN layers, interparticle spaces were more completely filled, and surface compactness was further increased. The literature suggests that due to its high surface area and layered architecture, hBN can envelope matrix surfaces more extensively at higher doses and generate a coating-like morphology [39]. This is in direct agreement with the microstructural observations of the present study. The marked increase in B and N intensities in EDX spectra of the 10% hBN group confirms the dominant surface presence of the additive. Although Ca and Si were not completely absent, their relative reduction indicates that the surfaces of MTA particles were largely covered by hBN, shaping the elemental composition at the measurement sites. Such surface coverage can lead to microtopographical changes that may alter cell–material interactions. Indeed, studies have reported that surface modification affects osteoblast adhesion, proliferation, and differentiation, and that nano-lamellar additives in particular can play a prominent role in modulating cellular behavior [40]. Therefore, the microstructural and chemical reorganization observed in the 10% hBN group is likely to contribute to the distinct tissue responses detected histologically. Taken as a whole, the SEM and EDX findings indicate that hBN modifies surface organization, increases apparent interparticle compactness, and alters the visible elemental profile of the composite surface without evidence of destructive chemical transformation of the MTA matrix. From a biomaterials perspective, this is important because such concentration-related changes in surface organization may influence how the defect environment interacts with the material. However, the present study measured histological endpoints only; it did not directly quantify protein adsorption, cell adhesion kinetics, or molecular osteogenic signaling. Therefore, the connection between microstructural change and biological response should be interpreted as plausible and hypothesis-generating rather than mechanistically proven. When interpreted together, the structural and microstructural findings add nuance to the histological results. The hBN-containing groups showed higher fibrous tissue scores than pure MTA and control, but they also exhibited higher new bone and osteoblastic cell presence scores. This pattern suggests that the fibrous/fibrovascular tissue observed at 8 weeks may represent an intermediate reparative compartment associated with ongoing matrix organization rather than a purely adverse foreign-body barrier [41]. Nevertheless, fibrous tissue should not be interpreted automatically as beneficial. Because only a single endpoint was evaluated, the present study cannot determine whether the observed fibrous tissue would mature into a more organized supportive interface, persist as a stable capsule, or diminish over time as remodeling progresses. A longer follow-up is therefore essential before assigning definitive biological valence to this finding. The present work used a rat tibial metaphyseal defect model rather than a calvarial defect model. This tibial design provides a reproducible orthotopic bony environment and permits standardized placement of the tested material within a defect surrounded by living bone tissue. Calvarial critical-size defect models remain another widely used platform for bone-regeneration studies and biomaterial screening [42–44]. At the same time, the unilateral right-tibia approach used here must be acknowledged as a methodological compromise: it kept the operative burden uniform and avoided bilateral surgery, but it also precluded paired within-animal comparison with the contralateral side. Future studies could incorporate bilateral or otherwise paired designs, where ethically and surgically appropriate, to reduce inter-animal variability and strengthen inference. There is substantial literature indicating that boron-containing systems and hBN-containing constructs can support mineralized tissue formation and upregulate osteogenesis-related markers in vitro and in vivo [10, 13, 45–49]. Composite scaffolds, coatings, and carrier systems containing hBN have been reported to enhance mineralized nodule formation, influence osteogenic gene expression, and support new bone formation in defect models [45, 48]. This broader evidence base is compatible with the direction of the present results, in which hBN-containing MTA groups showed higher new bone and osteoblastic cell presence scores than the empty-defect control. However, compatibility with the literature should not be mistaken for direct mechanistic confirmation within the present experiment. A particularly important interpretive point concerns the histological osteoblast-related endpoint. In the present study, the sections were scored for osteoblastic cell presence adjacent to the reparative tissue and newly formed bone; they were not analyzed by immunohistochemistry, enzyme activity assays, gene expression profiling, or other molecular markers of osteoblastic function. For this reason, the revised manuscript deliberately avoids overstatement such as “direct osteoblast activation” or “elevated osteoblast activity” and instead uses the more accurate phrase “higher osteoblastic cell presence scores”. On the other hand, the absence of statistically significant superiority of the hBN-containing groups over pure MTA for all endpoints underscores the already strong regenerative background of MTA itself. Calcium silicate cements such as MTA have repeatedly been reported to exhibit favorable hard-tissue response and good biocompatibility in intraosseous and soft-tissue models [50–54]. It is therefore plausible that the biologically active baseline of MTA narrows the observable margin for additional improvement. In this context, hBN should be interpreted as a potentially useful modifier of the response profile rather than as an additive that necessarily overwhelms the intrinsic osteoconductive potential of the base cement. The dose-related interpretation must also remain cautious. The lack of a statistically significant difference between MTA-5hBN and MTA-10hBN does not permit a definitive statement that 10 wt% is the universal optimum; it only indicates that, within the restricted range tested here, the 10 wt% formulation showed the most favorable overall descriptive trend relative to pure MTA. It remains entirely possible that a broader concentration series, alternative particle morphologies, or different follow-up intervals would identify a different response window. Thus, the current study narrows the field of plausible concentrations, but it does not close the optimization question. The same caution applies to translational interpretation. A material that appears promising in a short-term small-animal histology study still requires additional layers of validation before any strong clinical implication can be drawn. For a modified calcium silicate cement, these layers include mechanical stability after setting, resistance to washout or dissolution, ion-release behavior, dimensional stability, radiopacity retention, and absence of undesirable systemic or local accumulation effects. Moreover, if hBN is to be regarded as a clinically relevant additive, future work will need to establish not only whether it enhances bone-related healing but also whether it does so without compromising the handling and sealing expectations that make MTA valuable in endodontic use. The present data justify continuation of that program of work, but they do not complete it. As with any experimental study, several limitations must be emphasized explicitly. First, only a single 8-week healing period was evaluated, which limits interpretation of early inflammatory dynamics, intermediate fibrovascular organization, long-term remodeling, material persistence, and chronic defect maturation. Second, the biological endpoints were based on semi-quantitative histology rather than on fully quantitative bone-volume measurements, histomorphometry, or micro-computed tomography. Third, although structural analyses were broad in scope, they remained qualitative and did not include quantitative crystallographic modeling, mechanical testing, solubility analysis, ion-release profiling, or direct assessment of long-term hBN resorption. Finally, potential systemic distribution or organ-level accumulation of boron-containing species after prolonged exposure was outside the scope of the present 8-week design [36, 55]. Future studies should therefore extend the healing interval, incorporate micro-CT and histomorphometric quantification, measure mechanical and physicochemical properties relevant to clinical performance, and evaluate broader dose ranges and alternative hBN morphologies, ideally together with the more quantitative regeneration endpoints commonly reported in critical-size defect studies [56, 57]. Longer-term studies should also examine whether the fibrous/fibrovascular tissue observed here matures toward organized bone-supportive tissue or persists as an encapsulating interface. Together, such studies will be required before firm translational conclusions can be drawn regarding endodontic, periodontal, or orthopedic applicability of MTA-hBN composites. In summary, the present study provides integrated exploratory evidence that hBN can be incorporated into MTA without major loss of physicochemical identity and that such incorporation is accompanied by a modified 8-week fibro-osseous healing profile in rat tibial defects. The work does not establish a definitive optimum formulation, chronic safety profile, or direct cellular mechanism, but it does support continued investigation of hBN-reinforced calcium silicate cements as a technically plausible biomaterials strategy. Conclusions In this study, pure MTA, MTA + 5 wt% hBN, and MTA + 10 wt% hBN were evaluated in a rat tibial defect model using an integrated workflow that combined physicochemical characterization (XRD, FT-IR, SEM, EDX) with 8-week histological assessment. This design allowed the behavior of the modified cements to be examined at the level of phase preservation, microstructural organization, elemental detectability, and tissue response. The characterization results showed that hBN incorporation did not produce gross destabilization of the principal calcium silicate phase architecture of MTA. Instead, increasing hBN content was associated with progressively more visible additive-related spectral and elemental signals and with a denser apparent surface organization in SEM observations. Thus, within the tested range, hBN behaved as a physically coexisting reinforcing phase rather than as a chemically disruptive component of the cement matrix. Histologically, the hBN-containing groups demonstrated higher new bone and osteoblastic cell presence scores than untreated control defects, and the 10 wt% hBN formulation showed the most favorable overall trend relative to pure MTA among the concentrations tested. However, fibrous tissue scores were also higher in the hBN groups, meaning that the tissue response is better described as a modified fibro-osseous reparative pattern than as straightforward suppression of fibrosis. Importantly, the present data do not justify overstatement. The study did not directly measure osteoblastic activity at the molecular or enzymatic level, did not evaluate long-term remodeling beyond 8 weeks, and did not test a broad concentration series sufficient to define an absolute optimum. For these reasons, the appropriate conclusion is that hBN-reinforced MTA is promising within the boundaries of the current exploratory model, not that definitive concentration optimization or clinical superiority has already been proven. Overall, the results support continued development of hBN-reinforced mineral trioxide aggregate as a candidate biomaterial for applications in which preservation of MTA chemistry together with modulation of bone-related healing is desirable. Further work should now focus on quantitative bone-volume analysis, mechanical and physicochemical performance, longer-term biocompatibility and remodeling, dose-response mapping, and systemic safety before firm translational recommendations are made. Viewed in this way, the current manuscript should be understood as a deliberately detailed first-stage revision of the experimental record: it refines the reporting of the methodology, aligns the interpretation with the actual statistical and analytical boundaries of the data, and preserves the central scientific contribution of the study. The central message is not that hBN has already been proven clinically superior, but that hBN can be integrated into an MTA system in a technically plausible manner and that this integration is associated with a distinct reparative profile worthy of deeper investigation. That is a meaningful and appropriately bounded conclusion for an exploratory biomaterials study. Supplementary Information Supplementary Material 1. Acknowledgements The authors thank the Firat University Research Fund (TEK.25.63) for their financial contribution to this research and support. Abbreviations Mineral Trioxide Aggregate Hexagonal Boron Nitride X-ray Diffraction Fourier Transform Infrared Spectroscopy Scanning Electron Microscopy Energy-Dispersive X-ray Spectroscopy Calcium Silicate Hydrate Intraperitoneal Phosphate-Buffered Saline Weight% Calcium Hydroxide Calcium Carbonate Tricalcium Silicate Dicalcium Silicate Fourier Transform Infrared Magnesium Aluminium Silicon Calcium Oxygen Boron Nitrogen Hematoxylin–Eosin (histology staining) Statistical Package for the Social Sciences Animal Research: Reporting of In Vivo Experiments Standard Deviation Significance Level (Alpha) Micrometer Authors’ contributions Faruk Öztekin contributed to the study design, coordinated the experimental workflow, participated in the surgical procedures, and assisted in data interpretation and manuscript preparation. Cevher Kürşat Macit was responsible for the synthesis, preparation, and laboratory production of the MTA–hBN composite materials. Turan Gürgenç contributed to the material formulation process, including composite preparation, quality control of the produced samples, and laboratory support during structural characterization. Zeynep Toprak participated in the experimental protocol, assisted in surgical procedures, data collection, and contributed to the interpretation of histological and structural findings. Serkan Dündar contributed to the experimental design, assisted with the animal model procedures, data management, and manuscript revision. İbrahim Hanifi Özercan performed all pathological and histological procedures, including tissue processing, sectioning, staining, and microscopic evaluation. All authors reviewed, edited, and approved the final manuscript. Funding This research was supported by the Fırat University Research Fund under project number TEKF.25.63. Data availability The datasets generated and analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was approved by the Animal Experiments Ethics Committee of Firat University (Decision No: 2022/02). All procedures were performed in accordance with institutional guidelines for the care and use of laboratory animals and are reported in line with the ARRIVE 2.0 recommendations [24, 25]. All animals were housed within the institution, and no external owner consent was required. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.